Related references
Note: Only part of the references are listed.Omalizumab in the treatment of adult patients with mastocytosis: A systematic review
Fatma Jendoubi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors
Bianca Balbino et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Systemic mastocytosis with normal serum tryptase: rule or exception?
M. A. W. Hermans et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate
Emilie Perino et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair®)
J. D. M. Hughes et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2018)
Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial
Sandra Andorf et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
S. Broesby-Olsen et al.
ALLERGY (2018)
Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics
Phillip L. Lieberman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients
Laura Sanchez-Munoz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre
Maud A. W. Hermans et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Karin Hartmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis
Ivan Alvarez-Twose et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis
Tim Wiechers et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis
M. Arock et al.
LEUKEMIA (2015)
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis
P. Valent et al.
ALLERGY (2014)
Anaphylaxis as a Clinical Manifestation of Clonal Mast Cell Disorders
A. Matito et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2014)
The Mastocytosis Society Survey on Mast Cell Disorders: Patient Experiences and Perceptions
Susan Jennings et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis
Almudena Matito et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis
Jose M. Morgado et al.
HISTOPATHOLOGY (2013)
Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy
Kari C. Nadeau et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms
Peter Valent et al.
LEUKEMIA & LYMPHOMA (2011)
Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient
J. A. Douglass et al.
ALLERGY (2010)
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients
K. Brockow et al.
ALLERGY (2008)
Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma
Susan L. Limb et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain:: a study of the Spanish network on mastocytosis (REMA)
D. Gonzalez de Olano et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis
Melody C. Carter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Systemic mastocytosis: Clinical manifestations and differential diagnosis
Joseph H. Butterfield
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
Anti-IgE therapy
J Brownell et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2004)
Regulation of mast-cell and basophil function and survival by IgE
T Kawakami et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Share Paper
